Insomnia Therapy Market Size, Share 2022

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Insomnia Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insomnia Therapy Overall Market Size
2.1 Global Insomnia Therapy Market Size: 2021 VS 2028
2.2 Global Insomnia Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Insomnia Therapy Players in Global Market
3.2 Top Global Insomnia Therapy Companies Ranked by Revenue
3.3 Global Insomnia Therapy Revenue by Companies
3.4 Top 3 and Top 5 Insomnia Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Insomnia Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insomnia Therapy Players in Global Market
3.6.1 List of Global Tier 1 Insomnia Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Insomnia Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Insomnia Therapy Market Size Markets, 2021 & 2028
4.1.2 Non-pharmacological Therapy
4.1.3 Pharmacological Therapy
4.2 By Type - Global Insomnia Therapy Revenue & Forecasts
4.2.1 By Type - Global Insomnia Therapy Revenue, 2017-2022
4.2.2 By Type - Global Insomnia Therapy Revenue, 2023-2028
4.2.3 By Type - Global Insomnia Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insomnia Therapy Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Ambulatory Surgical Center
5.1.4 Home Care
5.2 By Application - Global Insomnia Therapy Revenue & Forecasts
5.2.1 By Application - Global Insomnia Therapy Revenue, 2017-2022
5.2.2 By Application - Global Insomnia Therapy Revenue, 2023-2028
5.2.3 By Application - Global Insomnia Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Insomnia Therapy Market Size, 2021 & 2028
6.2 By Region - Global Insomnia Therapy Revenue & Forecasts
6.2.1 By Region - Global Insomnia Therapy Revenue, 2017-2022
6.2.2 By Region - Global Insomnia Therapy Revenue, 2023-2028
6.2.3 By Region - Global Insomnia Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Insomnia Therapy Revenue, 2017-2028
6.3.2 US Insomnia Therapy Market Size, 2017-2028
6.3.3 Canada Insomnia Therapy Market Size, 2017-2028
6.3.4 Mexico Insomnia Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Insomnia Therapy Revenue, 2017-2028
6.4.2 Germany Insomnia Therapy Market Size, 2017-2028
6.4.3 France Insomnia Therapy Market Size, 2017-2028
6.4.4 U.K. Insomnia Therapy Market Size, 2017-2028
6.4.5 Italy Insomnia Therapy Market Size, 2017-2028
6.4.6 Russia Insomnia Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Insomnia Therapy Market Size, 2017-2028
6.4.8 Benelux Insomnia Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Insomnia Therapy Revenue, 2017-2028
6.5.2 China Insomnia Therapy Market Size, 2017-2028
6.5.3 Japan Insomnia Therapy Market Size, 2017-2028
6.5.4 South Korea Insomnia Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Insomnia Therapy Market Size, 2017-2028
6.5.6 India Insomnia Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Insomnia Therapy Revenue, 2017-2028
6.6.2 Brazil Insomnia Therapy Market Size, 2017-2028
6.6.3 Argentina Insomnia Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Insomnia Therapy Revenue, 2017-2028
6.7.2 Turkey Insomnia Therapy Market Size, 2017-2028
6.7.3 Israel Insomnia Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Insomnia Therapy Market Size, 2017-2028
6.7.5 UAE Insomnia Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Merck & Co.
7.1.1 Merck & Co. Corporate Summary
7.1.2 Merck & Co. Business Overview
7.1.3 Merck & Co. Insomnia Therapy Major Product Offerings
7.1.4 Merck & Co. Insomnia Therapy Revenue in Global Market (2017-2022)
7.1.5 Merck & Co. Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Insomnia Therapy Major Product Offerings
7.2.4 Sanofi Insomnia Therapy Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Insomnia Therapy Major Product Offerings
7.3.4 Pfizer Insomnia Therapy Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Takeda Pharmaceutical Company Ltd.
7.4.1 Takeda Pharmaceutical Company Ltd. Corporate Summary
7.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
7.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Major Product Offerings
7.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue in Global Market (2017-2022)
7.4.5 Takeda Pharmaceutical Company Ltd. Key News
7.5 Purdue Pharmaceuticals L.P.
7.5.1 Purdue Pharmaceuticals L.P. Corporate Summary
7.5.2 Purdue Pharmaceuticals L.P. Business Overview
7.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Major Product Offerings
7.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue in Global Market (2017-2022)
7.5.5 Purdue Pharmaceuticals L.P. Key News
7.6 Eisai, Co. Ltd.
7.6.1 Eisai, Co. Ltd. Corporate Summary
7.6.2 Eisai, Co. Ltd. Business Overview
7.6.3 Eisai, Co. Ltd. Insomnia Therapy Major Product Offerings
7.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue in Global Market (2017-2022)
7.6.5 Eisai, Co. Ltd. Key News
7.7 Meda Consumer Healthcare
7.7.1 Meda Consumer Healthcare Corporate Summary
7.7.2 Meda Consumer Healthcare Business Overview
7.7.3 Meda Consumer Healthcare Insomnia Therapy Major Product Offerings
7.7.4 Meda Consumer Healthcare Insomnia Therapy Revenue in Global Market (2017-2022)
7.7.5 Meda Consumer Healthcare Key News
7.8 Pernix Therapeutics
7.8.1 Pernix Therapeutics Corporate Summary
7.8.2 Pernix Therapeutics Business Overview
7.8.3 Pernix Therapeutics Insomnia Therapy Major Product Offerings
7.8.4 Pernix Therapeutics Insomnia Therapy Revenue in Global Market (2017-2022)
7.8.5 Pernix Therapeutics Key News
7.9 Vanda Pharmaceuticals
7.9.1 Vanda Pharmaceuticals Corporate Summary
7.9.2 Vanda Pharmaceuticals Business Overview
7.9.3 Vanda Pharmaceuticals Insomnia Therapy Major Product Offerings
7.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue in Global Market (2017-2022)
7.9.5 Vanda Pharmaceuticals Key News
7.10 ECR Pharmaceuticals
7.10.1 ECR Pharmaceuticals Corporate Summary
7.10.2 ECR Pharmaceuticals Business Overview
7.10.3 ECR Pharmaceuticals Insomnia Therapy Major Product Offerings
7.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue in Global Market (2017-2022)
7.10.5 ECR Pharmaceuticals Key News
7.11 Fidia Farmaceutici
7.11.1 Fidia Farmaceutici Corporate Summary
7.11.2 Fidia Farmaceutici Business Overview
7.11.3 Fidia Farmaceutici Insomnia Therapy Major Product Offerings
7.11.4 Fidia Farmaceutici Insomnia Therapy Revenue in Global Market (2017-2022)
7.11.5 Fidia Farmaceutici Key News
7.12 Dainippon Sumitomo
7.12.1 Dainippon Sumitomo Corporate Summary
7.12.2 Dainippon Sumitomo Business Overview
7.12.3 Dainippon Sumitomo Insomnia Therapy Major Product Offerings
7.12.4 Dainippon Sumitomo Insomnia Therapy Revenue in Global Market (2017-2022)
7.12.5 Dainippon Sumitomo Key News
7.13 Biocodex
7.13.1 Biocodex Corporate Summary
7.13.2 Biocodex Business Overview
7.13.3 Biocodex Insomnia Therapy Major Product Offerings
7.13.4 Biocodex Insomnia Therapy Revenue in Global Market (2017-2022)
7.13.5 Biocodex Key News
7.14 Eli Lilly and Company
7.14.1 Eli Lilly and Company Corporate Summary
7.14.2 Eli Lilly and Company Business Overview
7.14.3 Eli Lilly and Company Insomnia Therapy Major Product Offerings
7.14.4 Eli Lilly and Company Insomnia Therapy Revenue in Global Market (2017-2022)
7.14.5 Eli Lilly and Company Key News
7.15 Ebb Therapeutics
7.15.1 Ebb Therapeutics Corporate Summary
7.15.2 Ebb Therapeutics Business Overview
7.15.3 Ebb Therapeutics Insomnia Therapy Major Product Offerings
7.15.4 Ebb Therapeutics Insomnia Therapy Revenue in Global Market (2017-2022)
7.15.5 Ebb Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Insomnia Therapy Market Opportunities & Trends in Global Market
Table 2. Insomnia Therapy Market Drivers in Global Market
Table 3. Insomnia Therapy Market Restraints in Global Market
Table 4. Key Players of Insomnia Therapy in Global Market
Table 5. Top Insomnia Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Insomnia Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Insomnia Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Insomnia Therapy Product Type
Table 9. List of Global Tier 1 Insomnia Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insomnia Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Insomnia Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Insomnia Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Insomnia Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Insomnia Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Insomnia Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Insomnia Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Insomnia Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Insomnia Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Insomnia Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Insomnia Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Insomnia Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Insomnia Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Insomnia Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Insomnia Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Insomnia Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Insomnia Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Insomnia Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Insomnia Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Insomnia Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Merck & Co. Corporate Summary
Table 31. Merck & Co. Insomnia Therapy Product Offerings
Table 32. Merck & Co. Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Insomnia Therapy Product Offerings
Table 35. Sanofi Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Insomnia Therapy Product Offerings
Table 38. Pfizer Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Takeda Pharmaceutical Company Ltd. Corporate Summary
Table 40. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Offerings
Table 41. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Purdue Pharmaceuticals L.P. Corporate Summary
Table 43. Purdue Pharmaceuticals L.P. Insomnia Therapy Product Offerings
Table 44. Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Eisai, Co. Ltd. Corporate Summary
Table 46. Eisai, Co. Ltd. Insomnia Therapy Product Offerings
Table 47. Eisai, Co. Ltd. Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Meda Consumer Healthcare Corporate Summary
Table 49. Meda Consumer Healthcare Insomnia Therapy Product Offerings
Table 50. Meda Consumer Healthcare Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Pernix Therapeutics Corporate Summary
Table 52. Pernix Therapeutics Insomnia Therapy Product Offerings
Table 53. Pernix Therapeutics Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Vanda Pharmaceuticals Corporate Summary
Table 55. Vanda Pharmaceuticals Insomnia Therapy Product Offerings
Table 56. Vanda Pharmaceuticals Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 57. ECR Pharmaceuticals Corporate Summary
Table 58. ECR Pharmaceuticals Insomnia Therapy Product Offerings
Table 59. ECR Pharmaceuticals Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Fidia Farmaceutici Corporate Summary
Table 61. Fidia Farmaceutici Insomnia Therapy Product Offerings
Table 62. Fidia Farmaceutici Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 63. Dainippon Sumitomo Corporate Summary
Table 64. Dainippon Sumitomo Insomnia Therapy Product Offerings
Table 65. Dainippon Sumitomo Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 66. Biocodex Corporate Summary
Table 67. Biocodex Insomnia Therapy Product Offerings
Table 68. Biocodex Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 69. Eli Lilly and Company Corporate Summary
Table 70. Eli Lilly and Company Insomnia Therapy Product Offerings
Table 71. Eli Lilly and Company Insomnia Therapy Revenue (US$, Mn), (2017-2022)
Table 72. Ebb Therapeutics Corporate Summary
Table 73. Ebb Therapeutics Insomnia Therapy Product Offerings
Table 74. Ebb Therapeutics Insomnia Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Insomnia Therapy Segment by Type in 2021
Figure 2. Insomnia Therapy Segment by Application in 2021
Figure 3. Global Insomnia Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Insomnia Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Insomnia Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Insomnia Therapy Revenue in 2021
Figure 8. By Type - Global Insomnia Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Insomnia Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Insomnia Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Insomnia Therapy Revenue Market Share, 2017-2028
Figure 12. US Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Insomnia Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Insomnia Therapy Revenue Market Share, 2017-2028
Figure 24. China Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Insomnia Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Insomnia Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Insomnia Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Merck & Co. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eisai, Co. Ltd. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Meda Consumer Healthcare Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pernix Therapeutics Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Vanda Pharmaceuticals Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ECR Pharmaceuticals Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Fidia Farmaceutici Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Dainippon Sumitomo Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Biocodex Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Eli Lilly and Company Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Ebb Therapeutics Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

DOWNLOAD SAMPLE